Bioventus (BVS) EPS (Diluted) Growth (3y) (2025 - 2026)
Bioventus (BVS) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 63.42% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | 29.56% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | 30.57% |
| 10 | Bioventus | 828.42 Mn | 792.57 Mn | 90.77 Mn | 26.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 26.97% |
| Dec 31, 2025 | 38.55% |
| Sep 27, 2025 | 27.66% |
| Jun 28, 2025 | 216.49% |
| Mar 29, 2025 | -96.53% |